Latest SOX2 Stories
Discovery opens door to novel, small-molecule therapies for osteosarcoma NEW YORK, April 2, 2015 /PRNewswire-USNewswire/ -- A particular molecular pathway permits stem cells in pediatric
A new study from a team of Spanish and American scientists has described a more flexible approach to creating the valuable cells.
Scientists from Peking University, China and OriGene Technologies jointly published that multiple lineage specifier genes can replace OCT4 and SOX2, the core regulators of cell pluripotency.
Biologists reveal genes key to development of pluripotency, in single cells
Researchers at the RIKEN Omics Science Center (OSC) have successfully developed and demonstrated a new experimental technique for producing cells with specific functions through the artificial reconstruction of transcriptional regulatory networks.
Investigators at the Massachusetts General Hospital (MGH) Center for Regenerative Medicine and the Harvard Stem Cell Institute (HSCI) have found that Sox2 – one of the transcription factors used in the conversion of adult stem cells into induced pluripotent stem cells (iPSCs) – is expressed in many adult tissues where it had not been previously observed.
A team of scientists from Genome Institute of Singapore (GIS) of the Agency for Science, Technology and Research (A*STAR) have shown how proteins involved in controlling genes work together to carry out their functions in stem cells and demonstrated for the very first time, how they can change interaction partners to make other types of cells.
Like people with a big choice to make, stem cells have a process to "decide" whether to transform into a specific cell type or to stay flexible, a state that biologists call "pluripotency."
A new technique for reprogramming human adult cells could greatly improve the safety and efficiency of producing patient-specific stem cells for use in a range of therapeutic applications to repair or replace damaged or diseased tissues.
Singapore scientists' surprising discovery potentially relevant to cell-therapy-based medicine.
- A mania for the use of printing-types; a strong propensity to write for publication.